Plasma proteome analysis and validation of patients with community‐acquired pneumonia: A cohort study
PROTEOMICS – Clinical Applications · 2024-07 · 18 (4)
DOI: 10.1002/prca.202300069 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 08.02.2024. Verfasst von Lili Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Biomarkers, Community-Acquired Pneumonia, Plasma, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Chinese Science and Technology Key Project, National and Provincial Key Clinical Specialty Capacity Building Project 2020 (Department of the Respiratory Medicine).
Abstract (Originalsprache)
Purpose
This study aimed to investigate the diagnostic potential of plasma biomarkers of community‐acquired pneumonia (CAP) and their severity grading. Experimental design Plasma proteomes from cohort I ( n = 32) with CAP were analyzed by data‐independent acquisition mass spectrometry (MS). MetaboAnalyst 5.0 was used to statistically evaluate significant differences in proteins from different samples, and demographic and clinical data were recorded for all enrolled patients. Cohort II ( n = 80) was used to validate candidate biomarkers. Plasma protein levels were determined using quantitative enzyme‐linked immunosorbent assay (ELISA). Correlations were assessed using Pearson's correlation coefficient. A receiver operating characteristic curve was used to verify the association between the variables, CAP diagnosis, and prognosis.
Results
121 differentially expressed proteins (DEPs) were obtained between CAP and controls. These DEPs were mainly aggregated in pathways of phagosome(hsa04145) and complement and coagulation cascades (hsa04610). No significant differential proteins were detected in bacterial, viral, and mixed infection groups. The plasma levels of fetuin‐A, alpha‐1‐antichymotrypsin (AACT), α1‐acid glycoprotein (A1AG), and S100A8/S100A9 heterodimers detected by ELISA were consistent with those of MS. AACT, A1AG, S100A8/S100A9 heterodimer, and fetuin‐A can potentially be used as diagnostic predictors, and fetuin‐A and AACT are potential predictors of SCAP. Conclusions and clinical relevance Plasma protein profiling can successfully identify potential biomarkers for CAP diagnosis and disease severity assessment. These biomarkers should be further studied for their clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
- Department of Respiratory and Critical Care Medicine, Beijing Jishuitan Hospital, Beijing, China.
ORCID-Profile: Zhancheng Gao
Förderung
- Chinese Science and Technology Key Project
- National and Provincial Key Clinical Specialty Capacity Building Project 2020 (Department of the Respiratory Medicine)
Zitieren
APA
Zhao, L., Bian, W., Shang, Y., Zhi, H., Ma, X., He, Y., Yu, W., Liu, C., Xu, Y., Gong, P., & Gao, Z. (2024). Plasma proteome analysis and validation of patients with community‐acquired pneumonia: A cohort study. PROTEOMICS – Clinical Applications, 18(4). https://doi.org/10.1002/prca.202300069
Vancouver
Zhao L, Bian W, Shang Y, Zhi H, Ma X, He Y, et al. Plasma proteome analysis and validation of patients with community‐acquired pneumonia: A cohort study. PROTEOMICS – Clinical Applications. 2024;18(4). doi:10.1002/prca.202300069
BibTeX
@article{Zhao2024,
author = {Zhao, Lili and Bian, Wenjie and Shang, Ying and Zhi, Hui and Ma, Xinqian and He, Yukun and Yu, Wenyi and Liu, Chunyu and Xu, Yu and Gong, Pihua and Gao, Zhancheng},
title = {Plasma proteome analysis and validation of patients with community‐acquired pneumonia: A cohort study},
journal = {PROTEOMICS – Clinical Applications},
year = {2024},
volume = {18},
number = {4},
doi = {10.1002/prca.202300069}
}
EUVIMED